Indefinite Delivery Contract SPE2DU25D8018

Award Date 7/1/25
Last Date to Order 3/6/36
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Cardinal Health, Inc. as the prime contractor. The IDC, valued at $4,999,999.00, is for the provision of pharmaceutical, medical, and radiopharmaceutical products to support the Department of Defense (DoD), United States Coast Guard, and other government agencies globally. The contract aims to establish a Pharmaceutical Prime...
The federal contract IDV award is for an Indefinite Delivery Contract (IDC) from the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Cardinal Health, Inc. as the prime contractor. The contract has a ceiling value of $4,999,999.00 and a period of performance from July 1, 2025 to March 6, 2036. The contract is part of the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) procurement, which aims to establish multiple Prime Vendor Contracts to provide...
The federal contract IDV award to Cardinal Health, Inc. is for a Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) contract, valued at up to $999,999,999.00, with the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain as the funding agency. This single-award, indefinite delivery contract is intended to provide worldwide pharmaceutical support, including brand, generic, and specialty pharmaceuticals, to the Department of Defense (DoD), United States Coast Guard,...
The federal contract IDV award to Cardinal Health, Inc. is a single-award Indefinite Delivery Contract (IDC) valued at $76,117,431.74 with a period of performance from March 7, 2025, to March 6, 2035. The contract is with the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain, a defense agency, to provide pharmaceutical (brand, generic, specialty) and pharmaceutical-related products worldwide to the Department of Defense (DoD), United States Coast Guard, and other designated...
The federal contract IDV award is a Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain. The single-award IDC, valued at $999,999,999, was awarded to Amerisourcebergen Drug Corp for a base period of 30 months and three 30-month option periods, with a total estimated value of $30.3 billion. The contract aims to establish Prime Vendor Contracts for the PPV-G program, which provides worldwide...
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain has awarded an Indefinite Delivery Contract (IDC) with a total ceiling value of $4,999,999.00 to Cardinal Health, Inc. for the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) contract. This single-award IDC, with a period of performance from July 1, 2025 to March 6, 2036, aims to establish prime vendor contracts for providing worldwide pharmaceutical support, including brand, generic, and specialty drugs,...
The federal contract IDV award is for a Pharmaceutical Prime Vendor Global Program to provide worldwide pharmaceutical support to various Department of Defense (DoD) customers, including the Defense Health Agency (DHA), United States Coast Guard, and U.S. Naval Fleet. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is an Indefinite...
This is a single-award Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Cardinal Health, Inc. to provide pharmaceutical prime vendor support to the Department of Defense (DoD), United States Coast Guard, and other designated government customers. The contract has a 30-month base period and three 30-month option periods, with a total estimated value of $30.3 billion. The purpose of the contract is to establish a Pharmaceutical...
The federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $999,999,999 IDC has a period of performance through December 2036 and is designated as the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) contract. The purpose of this IDC is to establish prime vendor contracts to provide worldwide...
The federal contract IDV award is a Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) contract issued by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain. The contract, valued at up to $999,999,999, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide worldwide pharmaceutical support to various DoD customers, including the Defense Health Agency, U.S. Coast Guard, and U.S. Naval Fleet. The contract covers an...

The federal contract IDV award is a Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) contract issued by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain. The single-award IDV is valued at up to $999,999,999 and has a period of performance from July 1, 2025 to March 6, 2036. The prime contractor is Cardinal Health, Inc., a global healthcare services and products company.

The contract aims to establish Prime Vendor Contracts to provide worldwide pharmaceutical support, including brand, generic, and specialty pharmaceuticals, to the Defense Health Agency, Department of Defense, United States Coast Guard, and other government customers. The scope covers normal day-to-day operations as well as planned and unplanned contingency, Prime Vendor Readiness, and War Readiness Materiel support to CONUS and OCONUS locations. The contract utilizes a Lowest Price Technically Acceptable (LPTA) acquisition strategy, with the option to leverage reverse auctions to obtain the best distribution fees. The contract has a 30-month base period with three 30-month option periods, for a total estimated value of $30.3 billion across multiple regional awards.

Generated 6/6/25, 9:47 AM